Bringing together London’s leading institutions and innovators to solve today’s biggest healthcare challenges  

Create real world impact from your research and turn your MedTech idea into a commercial reality with the MedTech SuperConnector™

Up to £200,000 of

project support*

Create real world impact from your research and turn your MedTech idea into a commercial reality with the MedTech SuperConnector™ (MTSC) – a new eight-month* entrepreneurial training programme for Early Career Researchers (ECRs) with possible extension.
Gain access to expert business mentoring and entrepreneurial training with funding allowances for prototyping/consumables, facilities access, travel and your salary. Create connections with industry partners, potential investors and develop your technology with up to the value of £200,000* in support for your project.

APPLICATIONS FOR COHORT ONE ARE NOW CLOSED

*£40,000 in funding + £160,000 in services including desk space, and access to training, mentorship and Masterclasses.

MTSC Funding

 ECRs will receive:
  • Consumables Allowance (administered by your P.I.)

  • Travel Allowance (administered by your P.I.)

  • Entrepreneurship Training

  • Business Mentoring 

  • Access to Incubator/Accelerator Facilities

  • Access to Industry Networks

Principal Investigators will receive:
  • Opportunity to Translate Research

  • Consumables Allowance for Prototype Development

  • Salary Replacement for ECRs Released onto the Programme

Eligibility

MTSC is open to ECRs and Post-Docs currently in the lab at our partner Institutions.
You must have a medical device, diagnostic or eHealth solution or idea you wish to commercially develop. You must have the support from your P.I. to be on the programme.

Programme Dates:
  • Deadline for Applications 07.00, Monday 30th April 2018

  • Shortlisted Applicants notified Friday 11th May 2018

  • Pre-Pitch 0.5 day training Friday 18th May 2018

  • Final Presentations to Judging Panel Friday 25th May 2018

  • First Cohort announced Thursday 31st May 2018

  • MTSC Accelerator Start Date Monday 18th June 2018

Introducing MTSC Cohort One

ELISA FONTANA
ELISA FONTANA

The Institute of Cancer Research

Companion diagnostic assays for personalised therapies in gastrointestinal cancers that use robust gene-expression biomarkers

SAM WILSON
SAM WILSON

Imperial College London

NU Interface: An unobtrusive wearable system for detecting muscle vibration that generates real-time communication instructions e.g. to direct a prosthetic limb

LETIZIA GIONFRIDA
LETIZIA GIONFRIDA

Imperial College London

Med-K.ai™: an all-in-one AI platform that predicts musculoskeletal disorders through machine learning and computer vision

GEORGE WINFIELD
GEORGE WINFIELD

Imperial College London

SPYRAS: A paper-based breathing monitoring system that uses AI for early detection of patient deterioration

CAROLINE YAN ZHENG
CAROLINE YAN ZHENG

Royal College of Art

Pulse: a state of the art wearable soft robotic that mimics human-like touch for mental health therapeutic applications

BEN SWIFT
BEN SWIFT

The Royal Veterinary College

A novel phage-based technology to rapidly identify and detect antibiotic resistance in mycobacterial infections

GEORGE WADDELL
GEORGE WADDELL

Royal College of Music

MedStudio: a digital training platform which utilises self- and peer-evaluation to improve healthcare professionals’ ability to perform effective and empathetic patient interactions

ROMEO RACZ
ROMEO RACZ

The Francis Crick Institute

jULIEs Bioelectronics: next-gen neuroelectronic brain implant for neurological mapping and neuromodulation

UGUR TANRIVERDI
UGUR TANRIVERDI

Imperial College London

Ro/liner: A soft robotic liner for prosthetics which uses AI to adapt to limb shape changes throughout the day

ROSLIND HANNEN
ROSLIND HANNEN

Queen Mary University of London

A novel skin culture device that circumvents the limitations of standard methods to improve skin modelling and pharmaceutical testing


Launch of London’s pioneering MedTech accelerator

“Together we will build enduring value in medical technologies. The benefits will be felt by patients throughout the UK and around the world.”  – Professor Nick Jennings, Vice-Provost (Research & Innovation)

MTSC Insights: Knowledge Exchange

The MedTech SuperConnector is an open experiment in acceleration, bringing together talented early career researchers (ECRs), academic discoveries and pooled know-how from 8 academic institutions with 3 bioscience incubators, industry expertise, NHS patients and enabling partners (investors, service providers, mentors etc.) to determine the most effective methods for the translation of MedTech discoveries into clinical practice and consumer use.

Since April 2018, we have worked hard as a consortium to develop a series of tools, resources and methods helping us to successfully launch the inaugural MTSC Cohort in June 2018. We are now sharing our early findings to allow for the open reporting of processes and outputs that will form a valuable pool of hard evidence on best Knowledge Exchange (KE) practice, helping enable real-time learning across the HE sector.

Design
  • Project governance structures, Working Groups, Steering Board and Reporting Mechanisms Setup and Deployed.
  • HEI Consortium Agreement drafted, signed and implemented. 
  • Mechanisms and processes in paces for the disbursement of funds for Ventures and HEIs.
Accelerator Planning
  • Accelerator Programme design, structure and delivery. 
  • Application, selection, recruitment and On-boarding of participants. 
  • Branding, marketing and communications.
Industry Engagement
  • Launch Event, June 2018
  • Setup of MTSC Venture Mentor Service (MVMS).
  • Leveraging existing networks and contacts from across the consortium to engage with Industry; from Corporates, Investors, Service Providers and Mentors. 

Funded by Research England, MTSC is an initiative from a consortium of eight dynamic London universities with interest in nurturing talent, ideas, and entrepreneurship. MTSC will focus uniquely on a new route for Post-Docs and graduate students, to translate MedTech discoveries from academic labs into startup companies, proposing more solutions to today’s health challenges.